Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Diverse and cancer type‑specific roles of the p53 R248Q gain‑of‑function mutation in cancer migration and invasiveness.
Int J Oncol. 2019 Apr;54(4):1168-1182. doi: 10.3892/ijo.2019.4723. Epub 2019 Feb 22.
Int J Oncol. 2019.
PMID: 30968154
Free PMC article.
[ID proteins in tumour initiation and progression].
Pruszko M, Żylicz A.
Pruszko M, et al.
Postepy Biochem. 2016;62(4):449-458.
Postepy Biochem. 2016.
PMID: 28132447
Review.
Polish.
Item in Clipboard
The mutant p53-ID4 complex controls VEGFA isoforms by recruiting lncRNA MALAT1.
Pruszko M, Milano E, Forcato M, Donzelli S, Ganci F, Di Agostino S, De Panfilis S, Fazi F, Bates DO, Bicciato S, Zylicz M, Zylicz A, Blandino G, Fontemaggi G.
Pruszko M, et al.
EMBO Rep. 2017 Aug;18(8):1331-1351. doi: 10.15252/embr.201643370. Epub 2017 Jun 26.
EMBO Rep. 2017.
PMID: 28652379
Free PMC article.
Item in Clipboard
Expression of ID4 protein in breast cancer cells induces reprogramming of tumour-associated macrophages.
Donzelli S, Milano E, Pruszko M, Sacconi A, Masciarelli S, Iosue I, Melucci E, Gallo E, Terrenato I, Mottolese M, Zylicz M, Zylicz A, Fazi F, Blandino G, Fontemaggi G.
Donzelli S, et al. Among authors: pruszko m.
Breast Cancer Res. 2018 Jun 19;20(1):59. doi: 10.1186/s13058-018-0990-2.
Breast Cancer Res. 2018.
PMID: 29921315
Free PMC article.
Item in Clipboard
Zebrafish as experimental model to establish the contribution of mutant p53 and ID4 to breast cancer angiogenesis in vivo.
Pruszko M, Milano E, Zylicz A, Zylicz M, Blandino G, Fontemaggi G.
Pruszko M, et al.
J Thorac Dis. 2018 Mar;10(3):E231-E233. doi: 10.21037/jtd.2018.03.86.
J Thorac Dis. 2018.
PMID: 29708138
Free PMC article.
No abstract available.
Item in Clipboard
Wild-type p53 oligomerizes more efficiently than p53 hot-spot mutants and overcomes mutant p53 gain-of-function via a "dominant-positive" mechanism.
Walerych D, Pruszko M, Zyla L, Wezyk M, Gaweda-Walerych K, Zylicz A.
Walerych D, et al. Among authors: pruszko m.
Oncotarget. 2018 Aug 10;9(62):32063-32080. doi: 10.18632/oncotarget.25944. eCollection 2018 Aug 10.
Oncotarget. 2018.
PMID: 30174797
Free PMC article.
Item in Clipboard
Cite
Cite